Sahm Adrangi is the founder of Kerrisdale Capital. Many people believe hedge funds have had their time in the spotlight, and their 10 minutes is up. Sahm Adrangi is busy proving those people wrong. Along with his company, Sahm Adrangi are keeping alive by making wise investments.

A hedge fund is a company that uses other people’s money to invest across a wide variety of stocks. When the money comes back the hedge fund pays their investors and begins investing again. Hedge funds can be quite a great way to make cash, but they also come with a variety of their own problems.

Kerrisdale Capital tend to focus on pharmaceuticals and land development for their investing. Kerrisdale is able to make these wise decisions due to Adrangi’s foresight into these industries. In fact, he has made several predictions correctly in recent memory. These decisions prevented his company, and many others, from investing into pharmaceuticals that ultimately failed. When Bavarian Nordic claimed to have a vaccine for cancer, the investing world was on fire. However, Sahm Adrangi refused to invest in the company and warned others to follow his lead. Sahm Adrangi also called out another type of medicine for its inevitable failure. Adrangi said NEOD001, which is a AL amyloidosis drug, is destined to fail.

Adrangi and his company are also warning against St. Joe, a company that is attempting to renovate dilapidated land in Florida. They believe St. Joe will ultimately fail in their goals because their long-term goes simply seem impossible. Kerrisdale is saying that St. Joe’s shares are actually worth 40% less than what they are currently selling for.

About Sahm Adrangi

Adrangi was only 30 in 2011 when he made his first couple million dollars. He accomplished this by shorting Chinese companies that were listed on the U.S. stock exchange. By 2013, Adrangi’s fund had $250 million under management.

Adrangi and his company have made a name for themselves on social media, frequently tweeting out their philosophies, ideas, and purchases.